Correlation Between Aerovate Therapeutics and China Railway

Can any of the company-specific risk be diversified away by investing in both Aerovate Therapeutics and China Railway at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aerovate Therapeutics and China Railway into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Aerovate Therapeutics and China Railway Group, you can compare the effects of market volatilities on Aerovate Therapeutics and China Railway and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aerovate Therapeutics with a short position of China Railway. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aerovate Therapeutics and China Railway.

Diversification Opportunities for Aerovate Therapeutics and China Railway

0.1

Correlation Coefficient

Aerovate Therapeutics  China Railway

Average diversification

The 3 months correlation between Aerovate and China is 0.1. Overlapping area represents the amount of risk that can be diversified away by holding Aerovate Therapeutics and China Railway Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on China Railway Group and Aerovate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aerovate Therapeutics are associated (or correlated) with China Railway. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of China Railway Group has no effect on the direction of Aerovate Therapeutics i.e., Aerovate Therapeutics and China Railway go up and down completely randomly.

Pair Corralation between Aerovate Therapeutics and China Railway

Given the investment horizon of 90 days Aerovate Therapeutics is expected to under-perform the China Railway. But the stock apears to be less risky and, when comparing its historical volatility, Aerovate Therapeutics is 1.43 times less risky than China Railway. The stock trades about -0.03 of its potential returns per unit of risk. The China Railway Group is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  50.00  in China Railway Group on December 26, 2024 and sell it today you would earn a total of  3.00  from holding China Railway Group or generate 6.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Aerovate Therapeutics  vs.  China Railway Group

Aerovate Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Aerovate Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Aerovate Therapeutics is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

China Railway Group

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in China Railway Group are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, China Railway may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Pair Trading with Aerovate Therapeutics and China Railway

The main advantage of trading using opposite Aerovate Therapeutics and China Railway positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aerovate Therapeutics position performs unexpectedly, China Railway can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in China Railway will offset losses from the drop in China Railway's long position.

The idea behind Aerovate Therapeutics and China Railway Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.